Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,254 | 220 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $458.01 | 30 | $0 (2023) |
| AbbVie Inc. | $276.92 | 22 | $0 (2023) |
| Novo Nordisk Inc | $253.89 | 17 | $0 (2023) |
| Lilly USA, LLC | $245.82 | 16 | $0 (2023) |
| Merck Sharp & Dohme LLC | $219.63 | 16 | $0 (2023) |
| PFIZER INC. | $210.09 | 14 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $204.55 | 11 | $0 (2023) |
| GlaxoSmithKline, LLC. | $178.10 | 13 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $148.42 | 11 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $131.70 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $539.56 | 32 | Lilly USA, LLC ($98.26) |
| 2022 | $1,270 | 83 | ABBVIE INC. ($202.77) |
| 2021 | $357.77 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($101.14) |
| 2020 | $312.71 | 23 | GlaxoSmithKline, LLC. ($42.14) |
| 2019 | $691.63 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($86.43) |
| 2018 | $22.75 | 2 | Merck Sharp & Dohme Corporation ($22.75) |
| 2017 | $59.40 | 4 | Merck Sharp & Dohme Corporation ($25.09) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/25/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neuroscience | ||||||
| 05/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 05/23/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 05/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/02/2023 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $26.15 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 04/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINES | ||||||
| 04/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 04/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 04/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/23/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: VACCINES | ||||||
| 02/22/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 02/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 02/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DIABETES | ||||||
| 02/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 01/27/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 192 | 230 | $60,321 | $18,804 |
| 2022 | 11 | 424 | 561 | $129,822 | $41,228 |
| 2021 | 13 | 359 | 442 | $62,393 | $32,948 |
| 2020 | 8 | 240 | 328 | $44,521 | $20,271 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 105 | $33,705 | $8,578 | 25.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $6,975 | $4,190 | 60.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $8,420 | $2,844 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 43 | $9,374 | $2,550 | 27.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $480.00 | $470.40 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $992.00 | $128.60 | 13.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 15 | 15 | $375.00 | $43.60 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 203 | $65,163 | $19,958 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 90 | $19,620 | $6,832 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $15,156 | $5,248 | 34.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 21 | $12,390 | $3,710 | 29.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $4,080 | $1,642 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,331 | $1,461 | 23.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $2,508 | $803.63 | 32.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $720.00 | $706.20 | 98.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $330.00 | $325.20 | 98.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 65 | 74 | $1,850 | $271.85 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 26 | 27 | $1,674 | $271.46 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 109 | $23,615 | $11,336 | 48.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 109 | $16,352 | $8,290 | 50.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 18 | 18 | $3,600 | $3,385 | 94.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $3,621 | $3,131 | 86.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $8,077 | $2,179 | 27.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,265 | $1,265 | 100.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 43 | 43 | $1,075 | $927.51 | 86.3% |
About Dr. Danielle Savage, MD
Dr. Danielle Savage, MD is a Internal Medicine healthcare provider based in Rockaway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891084083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Savage, MD has received a total of $3,254 in payments from pharmaceutical and medical device companies, with $539.56 received in 2023. These payments were reported across 220 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,254).
As a Medicare-enrolled provider, Savage has provided services to 1,215 Medicare beneficiaries, totaling 1,561 services with total Medicare billing of $113,252. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rockaway, NJ
- Active Since 03/29/2011
- Last Updated 12/10/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891084083
Products in Payments
- JARDIANCE (Drug) $573.16
- REXULTI (Drug) $204.55
- VRAYLAR (Drug) $179.03
- TRELEGY ELLIPTA (Drug) $121.77
- TRINTELLIX (Drug) $110.05
- XARELTO (Drug) $102.61
- CHANTIX (Drug) $92.22
- JANUVIA (Drug) $91.94
- Ozempic (Drug) $86.14
- Kerendia (Drug) $81.03
- FARXIGA (Drug) $76.69
- PREVNAR 20 (Biological) $71.88
- FREESTYLE LIBRE 2 (Device) $66.63
- ENTRESTO (Drug) $64.84
- NURTEC ODT (Drug) $56.96
- Rybelsus (Drug) $50.18
- Auvelity (Drug) $48.46
- Yupelri (Drug) $46.83
- QULIPTA (Drug) $46.63
- SPIRIVA RESPIMAT (Drug) $46.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockaway
Dr. Alan Puzino, Md, MD
Internal Medicine — Payments: $7,795
Shivangi Patel, M.d, M.D
Internal Medicine — Payments: $1,721
Dr. Michael Barth, M.d, M.D
Internal Medicine — Payments: $696.95
Madhavi Annavajjula, Md, MD
Internal Medicine — Payments: $249.60
Dr. Robert Melis, M.d, M.D
Internal Medicine